Oculoplastic Surgery Market Worth $11.0 Billion by 2026 | CAGR: 5.72%: Grand View Research, Inc.

SAN FRANCISCO, Nov. 26, 2019 /PRNewswire/ -- The global oculoplastic surgery market size is expected to reach USD 11.0 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.72% CAGR over the forecast period. The market is primarily driven by the rising geriatric population, increasing number of oculoplastic surgical procedures, and technological advancements in the medical aesthetics industry. Furthermore, increasing patient awareness and rising disposable income are also fueling the growth. Factors such as the rising disposable income, standard of living, social media influence, and awareness among people are anticipated to bode well for the growth.


Key suggestions from the report:

    --  North America accounted for the largest market share in 2018, owing to
        the presence of favorable reimbursement policies, presence of key
        players, and supportive government initiatives
    --  By procedure, eyelid segment accounted for the largest market share and
        is expected to maintain its dominance during the forecast period. In
        2015, over 1,264,702 eyelid surgeries were performed globally
    --  Browlift and forehead lift segment is expected to register the fastest
        growth during the forecast period owing to high adoption of this surgery
    --  Some of the key companies in the oculoplastic surgery market are Integra
        Life Sciences; Anthony Product, Inc.; Sklar Surgical Instruments; B.
        Braun Melsungen AG; Blink Medical Ltd.; Bolton Surgical Ltd.; Integra
        Life Sciences; and Karlz Storz. These players are focusing on new
        product launches to introduce advanced services

Read 110 page research report with ToC on "Oculoplastic Surgery Market Size, Share & Trends Analysis Report By Procedure (Eyelid, Face Lift, Brow Lift, Orbital Pediatric), By End Use (Hospitals and Clinics, Ambulatory Surgical Centers), And Segment Forecasts, 2019 - 2026'' at: https://www.grandviewresearch.com/industry-analysis/oculoplastic-surgery-market

According to the results from a survey conducted by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), social media has massive impact on aesthetics, especially in the way consumers perceive and project themselves. The survey results highlighted that 55% of facial plastic surgeons consulted patients who wanted to look better in selfies in 2017, showing a 13% increase from the previous year.

With a wide range of oculoplastic surgery procedures available in the market, more people are willing to undergo such treatment due their affordability and feasibility. Furthermore, rising medical tourism and better reimbursement policies are also boosting the market growth. According to the Journal of Medicine, the number of medical tourists to all countries was estimated to be 14 million to 16 million in 2017. The medical tourism market is anticipated to witness significant growth over the forecast period, which is expected to bode well for the overall market for oculoplastic surgery.

Grand View Research has segmented the global oculoplastic surgery market based on procedure, end use, and region:

    --  Oculoplastic Surgery Procedure Outlook (Revenue, USD Million, 2015 -
        --  Eyelid Surgery
        --  Face Lift
        --  Brow Lift & Forehead Lift
        --  Pediatric Oculoplastic surgery
        --  Orbital Surgery
    --  Oculoplastic Surgery End Use Outlook (Revenue, USD Million, 2015 - 2026)
        --  Hospitals & Clinics
        --  Ambulatory Surgical Centers
    --  Oculoplastic Surgery Regional Outlook (Revenue, USD Million, 2015 -
        --  North America
            --  U.S.
            --  Canada
        --  Europe
            --  Germany
            --  U.K.
            --  France
            --  Italy
            --  Spain
        --  Asia Pacific
            --  Japan
            --  China
            --  India
            --  South Korea
            --  Australia
        --  Latin America
            --  Mexico
            --  Brazil
            --  Argentina
            --  Colombia
        --  Middle East & Africa
            --  South Africa
            --  Saudi Arabia
            --  UAE

Find more research reports on Medical Devices Industry, by Grand View Research:

    --  Retinal Surgery Devices Market - The global retinal surgery devices
        market size was estimated at USD 1.56 billion in 2016 and is anticipated
        to grow at a CAGR of 7.8% during the forecast period.
    --  Laparotomy Sponge Market - The global laparotomy sponge market size was
        valued at USD 713.5 million in 2016.
    --  Cranial Implants Market - The global cranial implants market size was
        valued at USD 991.80 million in 2018 and is anticipated to expand at a
        CAGR of 6.4% by 2026.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

View original content:http://www.prnewswire.com/news-releases/oculoplastic-surgery-market-worth-11-0-billion-by-2026--cagr-5-72-grand-view-research-inc-300965155.html

SOURCE Grand View Research, Inc.